In pulmonary LCNEC, molecular profiling has identified distinct subtypes, such as small cell lung cancer (SCLC)-like variants characterized by concurrent TP53 and RB1 alterations and non-small cell lung cancer (NSCLC)-like variants that lack these co-alterations. This evidence concerns the gene TP53 and non-small cell lung carcinoma.